✨ Medicinal Product Notices




16 SEPTEMBER NEW ZEALAND GAZETTE

2941

Product: Micardis.
Active Ingredient: Telmisartan 40 mg.
Dosage Form: Tablet.
NZ Sponsor: Boehringer Ingelheim (NZ) Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.

Product: Micardis.
Active Ingredient: Telmisartan 80 mg.
Dosage Form: Tablet.
NZ Sponsor: Boehringer Ingelheim (NZ) Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.

Product: Pritor.
Active Ingredient: Telmisartan 40 mg.
Dosage Form: Tablet.
NZ Sponsor: Glaxo Wellcome New Zealand Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.

Product: Pritor.
Active Ingredient: Telmisartan 80 mg.
Dosage Form: Tablet.
NZ Sponsor: Glaxo Wellcome New Zealand Limited.
Manufacturer(s): Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany.

Product: Sandostatin LAR.
Active Ingredient: Octreotide acetate 11.2 mg.
Dosage Form: Powder for injection.
NZ Sponsor: Novartis New Zealand Limited.
Manufacturer(s): Novartis Pharma AG, (Manufacturing site), Basel, Switzerland.

Product: Sandostatin LAR.
Active Ingredient: Octreotide acetate 22.4 mg.
Dosage Form: Powder for injection.
NZ Sponsor: Novartis New Zealand Limited.
Manufacturer(s): Novartis Pharma AG, (Manufacturing site), Basel, Switzerland.

Product: Sandostatin LAR.
Active Ingredient: Octreotide acetate 33.6 mg.
Dosage Form: Powder for injection.
NZ Sponsor: Novartis New Zealand Limited.
Manufacturer(s): Novartis Pharma AG, (Manufacturing site), Basel, Switzerland.

Product: Solu-Medrol Act-O-Vial.
Active Ingredient: Methylprednisolone sodium succinate 728.67 mg equivalent to 500 mg of free base in 4 ml.
Dosage Form: Injection with diluent.
NZ Sponsor: Pharmacia & Upjohn.
Manufacturer(s): Pharmacia & Upjohn Company, Kalamazoo, Michigan, U.S.A.
Pharmacia & Upjohn NV/SA, Puurs, Belgium.

Dated this 13th day of September 1999.

G. R. BOYD,
Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go6814



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 123


NZLII PDF NZ Gazette 1999, No 123





✨ LLM interpretation of page content

πŸ₯ Approval of Micardis (Telmisartan) Tablets

πŸ₯ Health & Social Welfare
13 September 1999
Medicines, Approval, Micardis, Telmisartan, Tablets
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Approval of Pritor (Telmisartan) Tablets

πŸ₯ Health & Social Welfare
13 September 1999
Medicines, Approval, Pritor, Telmisartan, Tablets
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Approval of Sandostatin LAR (Octreotide acetate) Powder for Injection

πŸ₯ Health & Social Welfare
13 September 1999
Medicines, Approval, Sandostatin LAR, Octreotide acetate, Powder for injection
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Approval of Solu-Medrol Act-O-Vial (Methylprednisolone sodium succinate) Injection

πŸ₯ Health & Social Welfare
13 September 1999
Medicines, Approval, Solu-Medrol Act-O-Vial, Methylprednisolone sodium succinate, Injection
  • G. R. Boyd, Chief Advisor, Safety and Regulation